Used in the synthesis of fluorinated pharmaceuticals and bioactive compounds due to its unique trifluoromethyl group and amino acid structure. The compound serves as a building block in medicinal chemistry, particularly in developing drugs with improved metabolic stability and membrane permeability. Its fluorine content enhances binding selectivity and prolongs half-life in vivo. Commonly employed in research for designing enzyme inhibitors and neuroactive agents, especially targeting GABA receptors, owing to structural similarity to endogenous neurotransmitters. Also utilized in the preparation of specialty peptides and probes for biochemical studies.